Huntington's Disease and Huntington's Disease-like 2 (HDL2) in Martinique

Ignacio Antolin-Sanfeliz1, Anna-Gaelle Giguet-Valard1, Sophie Duclos1

  • 1Centre de Référence Caribéen des Maladies Neuromusculaires Rares, CHU de Martinique, Fort-de-France, France.

PubMed

Insights

Huntington

Area of Science:

  • Neurology
  • Genetics
  • Rare Diseases

Background:

  • Huntington's Disease-like 2 (HDL2) shares clinical similarities with Huntington's Disease (HD) and is primarily observed in individuals with African ancestry.
  • The prevalence and clinical characteristics of HDL2 and HD in the Caribbean, specifically Martinique, were previously underexplored.

Purpose of the Study:

  • To comprehensively characterize patients with Huntington's Disease (HD) and Huntington's Disease-like 2 (HDL2) in Martinique.
  • To compare the clinical features, genetic factors, and disease progression of HD and HDL2 in this population.

Main Methods:

  • Retrospective analysis of all HD and HDL2 patients over 20 years at a single neurology center in Martinique.
  • Collection of longitudinal clinical data, Unified Huntington's Disease Rating Scale (UHDRS) scores, and CAG repeat lengths.

Main Results:

  • The combined minimum prevalence of HD and HDL2 in Martinique was 7.77/100,000.
  • HDL2 patients were predominantly male (83%) with motor symptoms as the most frequent initial manifestation, similar to HD.
  • Both diseases exhibited negative correlation between repeat length and age of onset, progressive worsening of motor and functional scores in HDL2 mirroring HD, and significant inter- and intra-familial heterogeneity.

Conclusions:

  • HDL2 is nearly as prevalent as HD in Martinique, indicating its significant presence in the region.
  • The study confirms strong genotype-phenotype correlations and similar disease courses between HD and HDL2, while emphasizing HDL2's heterogeneity and germline instability.
  • The findings are limited by the small number of HDL2 families, necessitating cautious interpretation.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
108.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Genetic Lingo01:11

Genetic Lingo

Overview
113.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
983